DoNotAge is a UK-based longevity supplement company that sells urolithin A as a mitophagy activator and cellular health support compound. Their product has attracted growing interest from people exploring evidence-based approaches to healthy aging, but the relevant question is always the same: what does the research actually support, and does this product deserve the attention it receives?
This review examines what urolithin A is, how it works at a cellular level, what peer-reviewed human trials have found, and what to look for when evaluating any urolithin A supplement, including DoNotAge’s. All research claims below are tied to specific published studies. No cures or guarantees are implied.
Key Takeaways
- Urolithin A is a gut-derived metabolite of pomegranate ellagitannins; production from food is unreliable because it depends on individual gut microbiome composition.
- Its primary studied mechanism is mitophagy activation, the selective recycling of damaged mitochondria, which is thought to decline with age and which urolithin A is proposed to stimulate; the claim that it works differently from other autophagy inducers comes from a review, not a head-to-head trial [10][3].
- Human randomized trials have reported some secondary-measure gains in muscle endurance in older adults and resistance-trained athletes, but the older-adult trial missed its primary endpoints and the athlete trial’s authors state it did not show improved muscle strength [5][6].
- Preclinical research hints at anti-inflammatory and mood-related effects via BDNF and AMPK pathways, but these are not yet established in human trials.
- When evaluating DoNotAge or any urolithin A product, prioritize dose transparency, an independent certificate of analysis, and sourcing clarity over marketing language.
What Is Urolithin A and Where Does It Come From?
Urolithin A is a compound produced in the gut when intestinal bacteria break down ellagitannins: polyphenols concentrated in foods like pomegranates, walnuts, and certain berries. The ellagitannins themselves are not absorbed intact; they are metabolized in the colon into a family of compounds called urolithins, of which urolithin A is considered the most biologically active form [1]. This means your exposure to urolithin A from food depends almost entirely on which bacteria inhabit your colon: a factor that varies substantially between individuals.
Because gut microbiome composition determines how much urolithin A a person actually produces, direct supplementation has been studied as a way to deliver consistent amounts regardless of microbiome variability. A mouse study found that orally administered urolithin A was detectable only briefly after dosing and appeared to be rapidly metabolized [13][2], a reminder that absorption and tissue exposure are not the same thing.
The Core Mechanism: Mitophagy and Cellular Renewal
The central reason urolithin A appears in longevity research is its capacity to induce mitophagy: a selective form of cellular housekeeping in which the cell identifies damaged or dysfunctional mitochondria and routes them for recycling. Mitochondria accumulate damage over time; when this process goes unchecked, energy production becomes less efficient and cells become more vulnerable to oxidative stress. Mitophagy clears the backlog and creates conditions for healthier mitochondria to replace the old ones.
Research note: The Cell Reports Medicine trial in middle-aged adults was sponsored by Amazentis SA (maker of Mitopure/Timeline), and several authors are Amazentis employees, board members or scientific advisory board members [16].
A recent narrative review compares urolithin A with spermidine, another studied autophagy inducer, and argues they act differently; it is a review opinion, not a head-to-head trial [3]. No trial has tested the two together, so whether stacking them adds anything is unknown [3].
The downstream effects of restored mitophagy appear to reach beyond muscle tissue. Animal research found that pharmacologically inducing mitochondrial recycling reversed age-associated decline in hematopoietic (blood-forming) and immune cell populations [4]. Whether urolithin A produces equivalent immune-related effects in aging humans remains an open research question.
Human Clinical Evidence: Muscle Endurance and Mitochondrial Health
The most frequently cited human evidence comes from a randomized clinical trial published in JAMA Network Open, which found that urolithin A supplementation improved muscle endurance and mitochondrial health biomarkers in older adults compared to placebo [5]. This study moved beyond animal and cell models, but its primary endpoints (walking distance and muscle ATP production) did not differ significantly from placebo; muscle endurance, a secondary endpoint, favoured urolithin A [5].
A more recent 8-week randomized, double-blind, placebo-controlled trial extended the evidence to a younger, physically active population. In 20 male athletes undergoing resistance training, urolithin A improved repetitions to failure and isometric strength versus placebo, but gains in 1RM bench press and squat were not significant, the authors state the study did not show improved muscle strength, and C-reactive protein rose within the urolithin A group [6]. This was a very small trial of 20 trained men, so it cannot show that effects extend beyond older adults [6].
Other trials in athletes were less encouraging. In 42 highly trained male distance runners, 3000 m time trial performance was not significantly improved, and in a 20-player soccer pilot there were no group differences in sprint speed or jump power. The runners trial was supported by research funding from Amazentis, the maker of Mitopure [14][15].
Researchers reviewing nutritional strategies for muscle preservation during aging have identified mitochondrial dysfunction as a central mechanism of age-related decline, noting that compounds targeting mitochondrial quality, including urolithin A, are candidates for further study, since reviews note there is still no accepted therapy for muscle aging [11][12][7]. This provides the mechanistic rationale connecting the observed clinical improvements to the cellular biology.
Emerging Research: Inflammation and Mood
Outside the muscle-mitochondria axis, early-stage research has begun exploring urolithin A in other physiological contexts. Preclinical work has synthesized and tested serotonin and dopamine conjugates of urolithin A, finding anti-inflammatory properties in laboratory models [8]. This line of research is far from clinical translation but suggests the compound may interact with inflammatory pathways beyond its mitophagy function.
Separately, animal studies have observed antidepressant-like effects following urolithin A administration, with proposed mechanisms involving the AMPK/CREB/BDNF signaling pathway [9]. BDNF (brain-derived neurotrophic factor) supports neuronal survival and plasticity; its upregulation is a shared target of several studied antidepressant interventions. These findings are preliminary and do not constitute evidence that urolithin A treats or prevents depression in people. They do, however, point toward potential effects on brain biology that merit formal human investigation.
Evaluating DoNotAge's Urolithin A: Dose, Form, and Quality Assurance
DoNotAge markets urolithin A as part of their longevity supplement line, targeting consumers interested in cellular aging biology. When assessing any urolithin A product, including theirs, three practical factors matter most: dose, quality verification, and sourcing transparency. The human clinical trials that demonstrated measurable effects used doses in the range studied in [5] and [6]; products using significantly lower doses may not replicate what was observed in those trials.
Third-party testing is particularly important for urolithin A because it falls outside pharmaceutical regulation. A certificate of analysis (COA) from an accredited independent laboratory confirming identity, potency, and absence of heavy metals or microbial contaminants is the minimum credible quality signal. DoNotAge states they conduct third-party testing; prospective buyers should request or verify a current COA for the specific batch they are purchasing rather than relying solely on brand claims.
Urolithin A products on the market vary in form: some use proprietary processed forms and others use standard crystalline urolithin A. The published clinical evidence does not clearly establish that one form outperforms another for typical supplementation purposes, so dose accuracy and verifiable purity are more practically meaningful purchasing criteria than form-based marketing claims.
Who May Benefit and Who Should Exercise Caution
The strongest human evidence currently supports urolithin A for older adults experiencing age-related reductions in muscle endurance and for physically active individuals seeking to support mitochondrial function during training [5][6]. These two groups represent the populations studied in the most rigorous human trials to date.
Individuals with autoimmune conditions, those taking immunosuppressive medications, or people with conditions that affect autophagy regulation should speak with a physician before using urolithin A. Modulating mitophagy is generally considered beneficial in healthy aging contexts, but its interaction with medications or disease states that involve altered cellular recycling has not been characterized in clinical research.
Pregnant or breastfeeding individuals should avoid urolithin A supplementation given the absence of safety data in these populations. As with any supplement, anyone managing a chronic health condition or taking prescription drugs should seek qualified medical advice before starting.
🛒 Where to Buy Urolithin A
- Timeline Mitopure SoftgelsClinically studied
softgels, 500 mg/day: The clinically studied form (Amazentis); used in the human trials. - Pure Encapsulations Renual
caplique capsules, 250 mg Mitopure Urolithin A/serving (with resveratrol + CoQ10): adds resveratrol and CoQ10, a combination the published urolithin A trials did not test. - ProHealth Longevity Urolithin A
capsules, 500 mg: Longevity-focused brand, often higher dose. - Double Wood Urolithin A
capsules, 250-500 mg: Budget-friendly, widely available, COA on request.
As an Amazon Associate we earn from qualifying purchases. Prices and availability vary; verify dose and third-party testing before buying.
A Note on the Evidence
The evidence for urolithin A is encouraging but still developing; most human trials are short-term and conducted in specific populations (older adults, trained athletes), so findings may not generalize to all individuals. This article is for informational purposes only and does not constitute medical advice: consult a qualified healthcare professional before starting any new supplement, especially if you have a chronic health condition, take prescription medications, or are pregnant or breastfeeding.
Frequently Asked Questions
What does urolithin A actually do inside cells?
Urolithin A’s primary characterized function is inducing mitophagy: prompting cells to identify and recycle damaged mitochondria rather than allowing them to accumulate. A narrative review argues it acts differently from other autophagy-inducing compounds like spermidine, but no head-to-head trial exists [3], which may explain why the two compounds appear complementary rather than redundant.
Is there real human clinical evidence, or is this just animal research?
There is human clinical evidence. A randomized trial in older adults published in JAMA Network Open reported that muscle endurance, a secondary endpoint, was higher on urolithin A than placebo, while the primary endpoints did not differ significantly [5]. An 8-week double-blind, placebo-controlled study in 20 male athletes reported more repetitions to failure, but its authors state it did not show improved muscle strength [6]. Both are controlled trials, not observational studies.
Why not just eat pomegranates instead of taking a supplement?
Pomegranates contain ellagitannins that your gut bacteria convert into urolithin A, but this conversion depends on which bacteria you have: a highly variable trait [1]. A substantial portion of people lack the specific bacteria required for efficient conversion, meaning they produce little or no urolithin A from food regardless of intake. Supplementation bypasses that dependency.
Does urolithin A have effects beyond muscle and mitochondria?
Early research points to broader effects. Restoring mitochondrial recycling reversed age-related decline in immune and blood-forming cell populations in animal models [4], suggesting systemic reach. Preclinical work also found antidepressant-like effects through the AMPK/CREB/BDNF pathway [9]. Neither finding has been replicated in human clinical trials yet, so these remain preliminary signals rather than established benefits.
What dose has been used in the studies?
The human trials demonstrating muscle and mitochondrial benefits used doses in a range that is consistent with typical commercial supplement offerings [5][6]. Specific milligram amounts varied across trials. Products using substantially lower doses than those studied may not replicate the observed outcomes, and the optimal dose across different health goals has not been definitively established.
Is urolithin A safe to take long-term?
Short- and medium-term use in healthy adults appears well-tolerated based on the clinical trials conducted so far, with no serious adverse events reported in the cited studies [5][6]. Long-term safety data over multiple years is limited, and individuals with immune conditions, autoimmune disease, or those taking medications affecting autophagy or inflammation pathways should consult a physician before use.
References
- Zhao W et al. Preparative isolation and purification of urolithins from the intestinal metabolites of pomegranate ellagitannins by high-speed counter-current chromatography. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2015). PMID 25864012
- Lin IC et al. Absorption and Metabolism of Urolithin A and Ellagic Acid in Mice and Their Cytotoxicity in Human Colorectal Cancer Cells. Evidence-based complementary and alternative medicine : eCAM (2023). PMID 37706115
- Borsky P et al. Distinct roles of urolithin A and spermidine in mitophagy and autophagy: implications for dietary supplementation. Nutrition research reviews (2025). PMID 41404767
- Girotra M et al. Induction of mitochondrial recycling reverts age-associated decline of the hematopoietic and immune systems. Nature aging (2023). PMID 37653255
- Liu S et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA network open (2022). PMID 35050355
- Zhao H et al. Assessment of Urolithin A effects on muscle endurance, strength, inflammation, oxidative stress, and protein metabolism in male athletes with resistance training: an 8-week randomized, double-blind, placebo-controlled study. Journal of the International Society of Sports Nutrition (2024). PMID 39487653
- Broome SC et al. Mitochondria as Nutritional Targets to Maintain Muscle Health and Physical Function During Ageing. Sports medicine (Auckland, N.Z.) (2024). PMID 39060742
- Korczak M et al. Synthesis, characterization, and anti-inflammatory potential of serotonin- and dopamine-conjugates of urolithin A. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2025). PMID 40554288
- Di Y et al. Urolithin A Exhibits Antidepressant-like Effects by Modulating the AMPK/CREB/BDNF Pathway. Nutrients (2025). PMID 40732919
- Gao Z et al. Urolithin A protects against acetaminophen-induced liver injury in mice via sustained activation of Nrf2. International journal of biological sciences (2022). PMID 35342347
- Dao T et al. Sarcopenia and Muscle Aging: A Brief Overview. Endocrinology and metabolism (Seoul, Korea) (2020). PMID 33397034
- Ancel S et al. Strengthening muscle for healthy ageing: innovative treatments for sarcopenia. Nature reviews. Drug discovery (2026). PMID 42706321
- U.S. Food and Drug Administration Agency Response Letter GRAS Notice No. GRN 000791. U.S. Food and Drug Administration (2018). source
- Whitfield J et al. Evaluating the Impact of Urolithin A Supplementation on Running Performance, Recovery, and Mitochondrial Biomarkers in Highly Trained Male Distance Runners. Sports medicine (Auckland, N.Z.) (2025). PMID 40839339
- Monsalve Acevedo A et al. Effects of Urolithin A supplementation on performance and antioxidant status in academy soccer players during preseason: a pilot randomised controlled trial. Frontiers in nutrition (2025). PMID 41245402
- Singh A et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell reports. Medicine (2022). PMID 35584623
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.